Published in Liver on October 01, 1999
In vivo imaging of cerebral "peripheral benzodiazepine binding sites" in patients with hepatic encephalopathy. Gut (2005) 1.01
Multi-dimensional MR spectroscopy: towards a better understanding of hepatic encephalopathy. Metab Brain Dis (2011) 1.00
Current and future applications of magnetic resonance imaging and spectroscopy of the brain in hepatic encephalopathy. World J Gastroenterol (2006) 0.99
Evidence for altered hepatic gluconeogenesis in patients with cirrhosis using in vivo 31-phosphorus magnetic resonance spectroscopy. Gut (2001) 0.89
Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview. World J Gastroenterol (2015) 0.87
Increased availability of central benzodiazepine receptors in patients with chronic hepatic encephalopathy and alcohol related cirrhosis. Gut (2000) 0.83
Role of Magnetic Resonance in Understanding the Pathogenesis of Hepatic Encephalopathy. Magn Reson Insights (2008) 0.77
Hepatitis C virus infection, and neurological and psychiatric disorders - A review. J Adv Res (2016) 0.75
Alcohol's Effects on the Brain: Neuroimaging Results in Humans and Animal Models. Alcohol Res (2017) 0.75
Efficacy of traditional Chinese herbal therapy in adult atopic dermatitis. Lancet (1992) 4.75
Balsalazide is more effective and better tolerated than mesalamine in the treatment of acute ulcerative colitis. The Abacus Investigator Group. Gastroenterology (1998) 3.90
Quality-of-care appraisal in primary care: a quantitative method. Ann Intern Med (1975) 2.87
Pre-operative percutaneous transhepatic biliary drainage: the results of a controlled trial. Br J Surg (1984) 2.78
Global text matching for information retrieval. Science (1991) 2.69
Mice overexpressing human uncoupling protein-3 in skeletal muscle are hyperphagic and lean. Nature (2000) 2.56
Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis. Eur J Clin Invest (1982) 2.48
Quantitative fecal indium 111-labeled leukocyte excretion in the assessment of disease in Crohn's disease. Gastroenterology (1983) 2.37
Inhibitory effect of non-steroidal anti-inflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing. Lancet (1990) 2.22
Specialist investigation of obscure gastrointestinal bleeding. Gut (1987) 2.10
Immunotherapy-responsive seizure-like episodes with potassium channel antibodies. Neurology (2008) 2.06
Immune complexes in ulcerative colitis and Crohn's disease. Clin Exp Immunol (1977) 2.04
Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. A comparison with colonoscopy, histology, and fecal indium 111-granulocyte excretion. Gastroenterology (1986) 2.03
Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study. Gut (2005) 1.99
Indium-111 autologous leucocyte scanning: comparison with radiology for imaging the colon in inflammatory bowel disease. Br Med J (Clin Res Ed) (1982) 1.96
111Indium autologous leucocytes in inflammatory bowel disease. Gut (1983) 1.95
Coma after cardiac arrest. Brain (1974) 1.86
Selective transport of polymeric immunoglobulin A in bile. Quantitative relationships of monomeric and polymeric immunoglobulin A, immunoglobulin M, and other proteins in serum, bile, and saliva. J Clin Invest (1982) 1.84
Evidence of underdiagnosis of myasthenia gravis in older people. J Neurol Neurosurg Psychiatry (2003) 1.84
Observations on the reflex response to muscle vibration in man and its voluntary control. Brain (1969) 1.78
Human gene for physical performance. Nature (1998) 1.78
Magnetic resonance imaging of total body fat. J Appl Physiol (1985) (1998) 1.76
Decreased suppressor cell activity in inflammatory bowel disease. Clin Exp Immunol (1978) 1.75
Conflicting MRI signals from gliosis and neuronal vacuolation in prion diseases. Neuroreport (1999) 1.68
Clinical experience with 99mTc-hexamethylpropylene-amineoxime for labelling leucocytes and imaging inflammation. Lancet (1986) 1.66
Alteration in suppressor cell activity in chronic active hepatitis. Proc Natl Acad Sci U S A (1978) 1.57
Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy. J Biol Chem (1989) 1.54
Immune-complex mediated colitis in rabbits. An experimental model. Gut (1978) 1.54
Treatment of acute exacerbations of multiple sclerosis with intravenous methyl-prednisolone. J Neurol Neurosurg Psychiatry (1982) 1.53
Management of suspected viral encephalitis in adults--Association of British Neurologists and British Infection Association National Guidelines. J Infect (2011) 1.50
Chronic immune colitis in rabbits. Gut (1979) 1.46
Relation of triglyceride stores in skeletal muscle cells to central obesity and insulin sensitivity in European and South Asian men. Diabetologia (1999) 1.45
Differing acute phase responses in Crohn's disease and ulcerative colitis. Gut (1986) 1.44
Portal vein thrombosis in myeloproliferative disease. Uses of thrombolytic and antiplatelet treatment. BMJ (1990) 1.43
Pleural involvement in the carcinoid syndrome. Q J Med (1993) 1.42
The diagnosis of lameness associated with distal limb pathology in a horse: a comparison of radiography, computed tomography and magnetic resonance imaging. Vet J (1998) 1.39
Mapping the homotypic binding sites in CD31 and the role of CD31 adhesion in the formation of interendothelial cell contacts. J Cell Biol (1995) 1.38
Gianotti-Crosti syndrome in an infant following immunization. Pediatr Dermatol (2000) 1.38
Controlled trial comparing prednisolone with an elemental diet plus non-absorbable antibiotics in active Crohn's disease. Gut (1985) 1.35
C3 metabolism in ulcerative colitis and Crohn's disease. Clin Exp Immunol (1977) 1.34
Neurotensin secretion by fibrolamellar carcinoma of the liver. Lancet (1984) 1.34
A missense mutation in the zinc-finger domain of the human hairless gene underlies congenital atrichia in a family of Irish travellers. Am J Hum Genet (1998) 1.32
Exercise training reduces fatty acid availability and improves the insulin sensitivity of glucose metabolism. Diabetologia (2006) 1.29
Resistant starch improves insulin sensitivity in metabolic syndrome. Diabet Med (2010) 1.26
Non-alcoholic steatohepatitis associated with small intestinal diverticulosis and bacterial overgrowth. Hepatogastroenterology (1989) 1.25
Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients. Neurology (2012) 1.25
Peripheral blood monocyte cytokine production and acute phase response in inflammatory bowel disease. Gut (1992) 1.25
Diversity in levels of intracellular total creatine and triglycerides in human skeletal muscles observed by (1)H-MRS. J Appl Physiol (1985) (1999) 1.24
Proton MR spectroscopy of intracranial tumours: in vivo and in vitro studies. J Comput Assist Tomogr (1990) 1.24
Assignment of resonances for 'acute-phase' glycoproteins in high resolution proton NMR spectra of human blood plasma. FEBS Lett (1987) 1.24
The nephrotic syndrome associated with neoplasia: an unusual paraneoplastic syndrome. Report of a case and review of the literature. Am J Med (1976) 1.24
Influence of undersampling on magnetic resonance imaging measurements of intra-abdominal adipose tissue. Int J Obes Relat Metab Disord (2003) 1.21
Microsatellite instability in ulcerative colitis-associated colorectal dysplasias and cancers. Cancer Res (1994) 1.20
Remission of symptoms in carcinoid syndrome with a new 5-hydroxytryptamine M receptor antagonist. Br Med J (Clin Res Ed) (1987) 1.20
Atopic disorders and adult coeliac disease. Lancet (1976) 1.20
Enhancement of adenylate cyclase activity in S49 lymphoma cells by phorbol esters. Putative effect of C kinase on alpha s-GTP-catalytic subunit interaction. J Biol Chem (1985) 1.19
Cortical dysfunction in non-demented Parkinson's disease patients: a combined (31)P-MRS and (18)FDG-PET study. Brain (2000) 1.17
Assessment of disease activity in inflammatory bowel disease: a new approach using 111In granulocyte scanning. Br Med J (Clin Res Ed) (1983) 1.16
Incidental findings in healthy control research subjects using whole-body MRI. Eur J Radiol (2008) 1.14
The ineffectiveness of excitation of the primary endings of the muscle spindle by vibration as a respiratory stimulant in the decerebrate cat. J Physiol (1968) 1.14
In vivo and in vitro hepatic 31P magnetic resonance spectroscopy and electron microscopy of the cirrhotic liver. Liver (1997) 1.13
Alteration in T lymphocyte subpopulations in inflammatory bowel disease. Clin Exp Immunol (1980) 1.13
Serum ferritin assay and bone-marrow iron stores in patients on maintenance hemodialysis. Kidney Int (1980) 1.11
Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances. Hepatology (1995) 1.11
Animal models of acute hepatic failure. Int J Exp Pathol (2000) 1.10
111Indium autologous granulocytes in the detection of inflammatory bowel disease. Gut (1985) 1.09
The prevention and treatment of murine colitis using gene therapy with adenoviral vectors encoding IL-10. J Immunol (2001) 1.09
Physical properties of erythrocyte ghosts that determine susceptibility to secretory phospholipase A2. J Biol Chem (2001) 1.08
Why measure C reactive protein? Gut (1994) 1.07
Hepatocyte growth factor/scatter factor expression in human mammary epithelium. Am J Pathol (1994) 1.07
Campylobacter pylori, duodenal ulcer disease, and gastrin. BMJ (1989) 1.06
Veganism and its relationship with insulin resistance and intramyocellular lipid. Eur J Clin Nutr (2005) 1.06
Mechanisms by which intracellular calcium induces susceptibility to secretory phospholipase A2 in human erythrocytes. J Biol Chem (2001) 1.06
Humoral immune system in inflammatory bowel disease: I. Complement levels. Gut (1977) 1.05
Role of hepatic arterial embolisation in the carcinoid syndrome. Br Med J (Clin Res Ed) (1983) 1.05
Preferential loss of visceral fat following aerobic exercise, measured by magnetic resonance imaging. Lipids (2000) 1.05
Spontaneous suppressor cell function in inflammatory bowel disease. Dig Dis Sci (1981) 1.04
Human serum does contain a high molecular weight hepatocyte growth factor: studies pre- and post-hepatic resection. Biochem Biophys Res Commun (1986) 1.04
Briquet's syndrome--an unusual case of urticaria. J R Soc Med (1991) 1.04
Definition of the specific roles of lysolecithin and palmitic acid in altering the susceptibility of dipalmitoylphosphatidylcholine bilayers to phospholipase A2. Biochemistry (1998) 1.03
Adiposity induced by adenovirus 5 inoculation. Int J Obes (Lond) (2005) 1.03
Effects of nonsteroidal anti-inflammatory drugs and misoprostol on gastroduodenal epithelial proliferation in arthritis. Gastroenterology (1992) 1.01
Automatic analysis, theme generation, and summarization of machine-readable texts. Science (1994) 1.01
A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris. Acta Derm Venereol (2002) 1.01
Vascular anomalies of the gastrointestinal tract. Hepatogastroenterology (1984) 1.00
Phenytoin-induced pseudolymphoma. A report of a case and review of the literature. Br J Dermatol (1992) 1.00
The proton NMR spectrum in acute EAE: the significance of the change in the Cho:Cr ratio. Magn Reson Med (1993) 1.00
Etanercept: effective in the management of hidradenitis suppurativa. Br J Dermatol (2006) 1.00
Intracellular and extracellular skeletal muscle triglyceride metabolism during alternating intensity exercise in humans. J Physiol (1998) 1.00
Cell-mediated immune functions and immunoregulatory cells in Behçet's syndrome. Clin Exp Immunol (1982) 1.00
Whole body fat: content and distribution. Prog Nucl Magn Reson Spectrosc (2013) 0.99
Symptom response after palliative radiotherapy for patients with brain metastases. Eur J Cancer (2002) 0.99
Dimethyl sulphoxide induces a reduced growth rate, altered cell morphology and increased epidermal-growth-factor binding in Hep G2 cells. Biochem J (1991) 0.99
Treatment of haemobilia by selective arterial embolisation. Gut (1980) 0.99
Adiposity in children and adolescents: correlates and clinical consequences of fat stored in specific body depots. Pediatr Obes (2012) 0.98
Chronic liver disease due to hepatitis C. BMJ (1993) 0.98